Clinical trial

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler…

NCT00442351 · Organon and Co, Industry · Terminated

Key facts

NCT number NCT00442351
Title Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)
Official title A Comparative Study of The Efficacy and Tolerability of Maintenance Treatment of Patients With Mild/Moderate Persistent Asthma With Asmanex Twisthaler 220 mcg QD PM Versus "Asmanex" Placebo QD PM
Lead sponsor Organon and Co, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug, Other
Interventions Asmanex twisthaler, Placebo for Asmanex twisthaler
Enrollment 26
Start date Sep 1, 2006
Primary completion Apr 1, 2007
Completion Apr 1, 2007
First posted Mar 1, 2007
Last update posted Feb 9, 2022

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies